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 Skeletal muscle is the site at which highly regulated energetic processes take 
place as a means of maintaining both tissue-specific and whole-body metabolism.  
With the development of severe obesity (BMI ≥ 40 kg/m2), skeletal muscle often loses 
its ability to properly respond to insulin, which aside from regulating glucose, has also 
been suggested to regulate factors specific to mitochondrial biogenesis.  In this study, 
we classified human skeletal muscle cells (HSkMCs) derived from lean and severely 
obese individuals.  We found them to be strikingly similar with respect to their 
proliferation and differentiation behavior. Also, to test the hypothesis that insulin 
would increase proteins associated with mitochondrial biogenesis, mature myotubes 
were treated with 100nM insulin at time points ranging from 1-24 hours.  To validate 
our model, we incorporated a number of methodologies, including measures of AKT 
phosphorylation, which we found to be 51% lower in the obese group at the first hour 
(p = 0.05).  However, 100nM insulin produced no changes in protein content of PGC-
1α, nor OXPHOS proteins, Complex V or Complex III. This high-insulin treatment did 
result in increases in Complex IV at 3 hours (p = 0.02), as well as the slow isoform of 
  
MYHC (at multiple time points) in both groups.  We also observed trends for decreases 
in intracellular ATP at 24 hours of high-insulin treatment in both lean and severely 
obese groups. Collectively, these data demonstrate that insulin produces no 
consistent increases in mitochondrial biogenesis as defined by PGC-1α and OXPHOS 
proteins in myotubes from lean and severely obese individuals.  We further conclude 
that the responses to sustained, high-insulin exposure in these groups are alike as it 
relates to increases in protein synthesis (i.e., MYHC (slow)) at the rather costly 
expense of ATP. 
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Chapter I 
Introduction 
Currently affecting approximately one-third of the U.S. population [1], obesity, 
an over-expansion of the adipose tissue resulting in a Body Mass Index (BMI) ≥ 30 
kg/m2, is a disease state that results in skeletal muscle dysfunction.  Human skeletal 
muscle is an organ comprising less than half (roughly 40% for men and 30% for women) 
of total body mass [2].  It provides the support needed for bodily movement and is 
known for its key contributions to energy production with respect to athletic 
performance (i.e., power, force, velocity), thermoregulation and substrate 
metabolism.  In recent years, skeletal muscle has been studied extensively for its role 
in health and metabolic disease, such as obesity. As mentioned, obesity is far too 
prevalent in U.S., comprising about one-third of the population, with 1 in 20 
Americans being severely obese (BMI ≥ 40 kg/m2) [3].  Obesity has been closely linked 
to the development of cardiovascular disease as well as skeletal muscle insulin 
resistance and Type 2 Diabetes (T2D) [4].  As a result, understanding how obesity 
dictates energetic processes in skeletal muscle is of high concern. 
Insulin is an anabolic peptide hormone released from pancreatic β-cells for the 
control of blood glucose levels.  In skeletal muscle, the site at which ~80% of glucose 
uptake occurs [5], this process is defective in the state of obesity [6, 7, 8].  Though 
insulin sensitivity is primarily thought to be a crucial component of the regulation of 
glucose, there is a growing body of evidence to suggest insulin is also responsible for 
the regulation of other components of energy production [9, 10].  Though this 
relationship is still not fully established with respect to skeletal muscle, there is 
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evidence to suggest that insulin also regulates aspects of mitochondrial function [9, 
10]. 
The mitochondrion an organelle at which produces a high volume of energy in 
the form of adenosine triphosphate (ATP).  Both the content and function of 
mitochondria are reduced with severe obesity [11, 12], which contribute to the 
inflexibility of skeletal muscle in terms of substrate metabolism.  Whether this 
decrement in mitochondrial energetics precedes or is a result of the insulin-resistant 
state of skeletal muscle from obese individuals is debatable [13].  Nonetheless, insulin 
has been suggested to somehow be involved in the regulation of the mitochondria 
and/or subsequent function. Moreover, this contribution to mitochondrial metabolism 
may be tissue-specific.  For example, a study was conducted in which mitochondria 
were extracted from pancreatic β-cells derived from β-cell-specific insulin receptor 
knockout mice [14].  Major findings were that there was a decrease of function in 
factors associated with mitochondria, including an apoptotic protein, Bcl2-associatd 
death promoter (BAD).  These impairments were restored with expression of the same 
tissue/cell-specific receptors.  In mouse hepatocytes, however, it was found that 
insulin stimulation over a 24-hour time period, decreased mitochondrial content, ATP 
production and O2 consumption [15].  These data are in line with the idea of insulin as 
a regulatory factor of mitochondria that is specific to tissue type. 
In terms of skeletal muscle, a 2014 study found that 4 hours of insulin infusion 
in healthy individuals resulted in a 2-fold increase in phosphorylation of isolated 
mitochondrial proteins including those indicative of oxidative capacity and 
tricarboxylic acid (TCA) cycle function, to name few [16].  This is in agreement with   
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a study from 2003 that showed an 8-hour insulin infusion induced changes in ATP 
production that were accompanied with increases in measurements of mitochondrial 
function (citrate synthase (CS) and cytochrome oxidase (COX) activities) [17].  
However, it is important to note that the findings from this particular study were 
observed in patients with T2D [17].   
The extent to which the anabolic potential of insulin could enhance 
mitochondrial content and/or function in skeletal muscle in with obesity remains 
unclear.  Furthermore, there is a lacking in the literature concerning such changes 
and how they are altered with longer time durations in vitro.  The purpose of this 
study was to investigate if high-insulin exposure alters indices of mitochondrial 
content/function differently in the skeletal muscle from lean vs. obese individuals 
with a time course analysis.  For these experiments, we utilized a cell culture model 
in which we maintained a highly controlled environment that eliminated the influence 
of external factors (i.e., other hormones, exercise/physical activity) on the 
physiological conditions we aimed to study.  As mentioned, human skeletal muscle 
cells (HSkMCs) derived from severely obese individuals often exhibit reductions in 
glucose and lipid metabolism [44, 49].  Because of this, HSkMCs serve as a great 
model for studying metabolic dysfunction in certain populations (i.e., insulin 
resistant) [47, 48].  However, the authors wanted to evidence whether these 
differences were due to cellular properties (i.e., cell proliferation or differentiation, 
muscle cell machinery).   
We hypothesized that there would be no differences in proliferation or 
differentiation in HSkMCs derived from lean and severely obese individuals. 
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Additionally, we hypothesized that high-insulin would acutely upregulate factors 
associated with mitochondrial biogenesis in muscle from lean, but not obese 
individuals.  These factors include but are not limited to: peroxisome proliferator-
activated receptor gamma coactivator 1-alpha (PGC-1α) and proteins involved with 
the electron transport chain (Complexes I-V).  We further hypothesized insulin-
stimulated improvements in mitochondrial function in lean individuals, particularly 
citrate synthase activity and ATP content.  With these findings, it was our intent to 
provide additional evidence to the changes in response to insulin that may or may not 
occur in skeletal muscle with severe obesity.  
  
Chapter II 
Review of Literature 
Dangers of Obesity 
Skeletal Muscle Insulin Resistance 
 Obesity (BMI ≥ 30 kg/m2) is concerning due to its association with conditions 
such as hypertension and coronary artery disease, as well as the development of 
insulin resistance and type 2 diabetes.   In skeletal muscle, insulin-mediated glucose 
transport initially requires insulin to bind to the α-subunits on the transmembrane 
receptor on the cell surface [18].  This binding results in an intracellular signaling 
cascade that involves the phosphorylation of AKT (also known as Protein Kinase B), 
which stimulates the translocation of GLUT4 vesicles to the membrane allowing 
glucose uptake to occur [19-23].  Like many other signaling pathways in the human 
body, this is a tightly controlled and highly regulated system.  However, in the state 
of obesity, oftentimes glucose levels remain high, as well as the levels of insulin, 
indicating that this process is impaired. 
To determine if insulin signaling is impaired with obesity, intact muscle strips 
were teased from rectus abdominus muscle biopsy samples from 8 lean (BMI = 25.7 ± 
0.9 kg/m2) and 8 severely obese (BMI = 52.9 ± 3.6 kg/m2) individuals [24]. The 
participants were all women matched for age and race.  The muscle strips were 
measured for 2-deoxyglucose in both the basal and insulin-stimulated states.  Insulin-
stimulated glucose uptake was reduced by 53% in muscle strips obtained from the 
severely obese individuals in comparison to their lean counterparts.  Additional 
measures were taken for insulin signaling including the insulin receptor, insulin 
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receptor substrate-1 (IRS-1), and PI3K activity.  Muscle strips obtained (from the same 
participants) were incubated in basal or insulin-stimulated (10-7M) states for 2, 4, 15 
or 30 minutes).  These data indicated that at each time point, insulin-stimulated 
tyrosine phosphorylation of both the insulin receptor and IRS-1 were reduced in 
muscle strips from obese individuals compared to lean.  These differences reached 
statistical significance at 2 minutes and 15 minutes as well as in the basal state for 
the insulin receptor. However, only the 15 minute time point was significant for IRS-1.  
Furthermore, the researchers found that the regulatory subunit of PI3K, p85, was also 
reduced in muscle strips from severely obese individuals.  PI3K activity was reduced 
as well, suggesting that this reduced activity of PI3K could be due in part to 
decreased p85 expression [24].  Taken together, these and other findings [25, 26, 27] 
demonstrate that impairments in steps of the insulin signaling cascade serve as 
potential molecular mechanisms for skeletal muscle insulin resistance. 
Alterations in Muscle Properties & Fiber Type  
In addition to deficiencies in insulin signaling, research has suggested that 
obesity is associated with differences in the muscle cell properties including fiber 
type.  Recent data has shown that these cellular properties in diseased populations 
(i.e., individuals with T2D, COPD, other inflammatory diseases) are altered in 
comparison to their healthy counterparts.  These changes include, but are not limited 
to, changes in cell proliferation, differentiation and regeneration [50, 51, 52].  One 
particular group of researchers provided evidence to the oxidative function of primary 
muscle cells being retained up to the fifth passaging of the cells in cells from lean and
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individuals with T2D [53]. Still, there is a lacking in the research that has been done 
to address these questions with respect to obesity.   
With regards to fiber type, both type I and type II muscle fibers have been 
shown to respond to insulin [28, 29], though type I muscle fibers have been shown to 
be more insulin sensitive compared to type II fibers [29].  Additionally, decreased 
type I fibers have been observed in obese T2D patients [30], suggesting the insulin-
resistant state often accompanying obesity is related to the glycolytic capacity of 
muscle associated with fiber type. 
A group of researchers sought to further examine this phenomenon in a study in 
which they hypothesized that a relationship existed between muscle fiber type and 
obesity [31].  This study consisted of middle-aged Caucasian and African American 
women who were undergoing abdominal surgery and were either lean (undergoing 
hysterectomy), or obese (undergoing gastric bypass).  Body mass index (BMI) was 
compared across groups.  A rectus abdominus muscle biopsy was obtained from each 
of the participants who underwent surgery.  These samples were mounted, frozen, 
sliced in 10 µM sections and stained for ATPase for analysis of fiber type.  The data 
indicated that adiposity was positively correlated with muscle fiber type, specifically 
type IIb.  Moreover, all lean participants possessed roughly 55% type I fibers and about 
14% type IIb fibers. However, obese participants exhibited a significantly lower 
percentage of type I fibers as well as a significantly higher percentage of type IIb.  
Furthermore, African American participants contained lower percentages of type I 
fibers and subsequently higher percentages of type II fibers (in comparison to lean 
subjects).  This, as the authors mention, could be a plausible explanation as to why 
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African Americans are generally more likely to be obese and/or develop T2D or similar 
metabolic complications [31].   Lastly, participants with greater type I fiber 
percentages who underwent gastric bypass experienced greater reductions in 
adiposity, suggesting muscle fiber type may also play an important role in facilitating 
fat metabolism. 
Mitochondrial Dysfunction  
In addition to skeletal muscle insulin resistance and changes in fiber type, 
obesity has also been linked to reduced mitochondrial capacity and function.  
Deficiencies in proteins associated with mitochondrial biogenesis and fat oxidation 
have been observed [32].  Other complications as a result of obesity (i.e., 
mitochondrial morphology, dynamics) that are associated with skeletal muscle 
functionality are also of concern.  
Such complications were illustrated when a research group examined leptin-
deficient mice ((ob/ob), with control littermates) and high-fat diet mice (HFD), with 
low-fat diet controls [33].  Mouse myoblasts (C2C12s) were obtained and 
differentiated for experiments aimed to induce a shift in energy balance (i.e., 
hyperglycemia, palmitate incubation).  Measurements that were taken included an 
assessment of mitochondrial morphology, mtDNA content and mitochondrial protein.  
The major findings were that since mitochondrial fusion protein levels were 
unchanged, it was suggested that mitochondrial fission is where the problem may lie, 
as mitochondrial fragmentation was increased in ob/ob and HFD mice.  This 
fragmentation was associated with palmitate-induced increases in fission proteins, 
dynamin-related protein 1 (Drp1) and mitochondrial fission protein 1 (Fis1) in ob/ob 
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and HFD mice [33].  These data indicate that lipid overexposure associated with 
severe obesity, is damaging to mitochondria and their associated proliferation 
mechanisms. 
These findings are consistent with a 2011 study conducted in humans in which 
HSkMCs were obtained from young lean and severely obese Caucasian males [34].  
These cells were cultured, differentiated to myotubes and incubated with palmitoyl 
carnitine for 24 hours.  Following the lipid substrate incubation, measures for 
mitochondrial content and function were taken. Results indicated that mitochondrial 
DNA (mtDNA) copy number increased in myotubes from lean, but decreased in 
myotubes from obese donors.  Also, in myotubes from obese donors, mitochondrial 
respiration did not increase to the same degree of myotubes from lean individuals. 
Even after normalization to mitochondrial content (by mtDNA copy number and 
citrate synthase activity), data show a persistent reduction in fat oxidation after lipid 
treatment in myotubes from obese individuals [34]. These findings suggest that obese 
muscle is metabolically inflexible as only myotubes from lean individuals expressed 
the ability to induce mitochondrial proliferation and increase respiration following 
lipid exposure.  It can be concluded that reduced mitochondrial content and function 
are plausible explanations for altered fat metabolism in obese individuals.  
 Lastly, a study conducted with eight severely obese individuals undergoing 
bariatric surgery also highlights the inherent metabolic defects with mitochondria as a 
result of severe obesity [35].  In this study, permeabilized muscle fibers from muscle 
biopsies from each participant were analyzed using high-resolution respirometry to 
assess mitochondrial function.  The findings from these eight severely obese 
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individuals were compared to ten lean and ten obese individuals.  Before surgery, 
state 3 respiration was significantly lower in severely obese individuals.  This 
particular finding emphasizes the reduced function of mitochondria with severe 
obesity.  However, the remaining findings were that state 3 respiration increased 
after a mean of 35 kg weight loss by bariatric surgery.  Similarly, overall 
mitochondrial function in the severely obese individuals was comparable to that of 
lean individuals 1-year post surgery.  Furthermore, respiration on a lipid substrate 
also increased in muscle fibers from obese individuals.  These data suggest that 
though the mitochondria are defective in the obese state, dramatic weight loss can 
serve as a means to improve them.  In addition, this could mean that insulin as a 
stimulatory factor is also involved, as insulin sensitivity is also rapidly restored with 
bariatric surgery [35-38]. 
  
  
The Role of Insulin in Obesity/Metabolic Disease 
Regulation of Gene Expression & Protein Content by Insulin 
Though insulin has long been studied for its responsibilities to regulating small 
molecules like glucose [39], there is a collection of evidence that illustrates its 
effects on transcriptional regulation.  In the liver, insulin effects (via vanadate 
administration) have been shown to increase glucokinase, a critical enzyme 
responsible for the breakdown of glucose in hepatocytes.  Glucokinase mRNAs 
increased by 20-fold after only 45 minutes of vandate treatment in liver nuclei of 
streptozotocin-treated (STZ) rats [40].  Similar findings are evident in liver in a study 
investigating effects of insulin on gene expression, particularly glycolytic enzymes like 
pyruvate kinase [41].   
A more recent study was conducted examining this relationship in-vivo.  A 
hyperinsulinemic-euglycemic clamp was performed on 10 young males for 3 hours 
[42]. Vastus lateralis muscle biopsies taken before and after the clamp procedure 
indicated that hyperinsulinemia induced significant increases in myosin heavy chain 
(MYHC) type IIx mRNAs.  These data suggest that prolonged insulin exposure (at 600 
pmol ⋅ m−2 ⋅ min−1) has an effect on the gene expression of type II muscle fibers in 
vivo.  This may explain mechanisms of lower amounts of mitochondria in obese 
individuals who have higher percentages of these type II fibers.  Furthermore, an 
MYHC analysis in a recent study revealed that severely obese individuals exhibit 
significantly less of the type I isoform in comparison to their lean counterparts [43].  
Taken together, these studies offer evidence to a critical relationship between 
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obesity and the regulation of genes by insulin in glycolytic as well as oxidative 
metabolism. 
Mitochondrial Content is altered in Skeletal Muscle with Insulin Exposure 
 The mitochondria, which handle the vast majority of oxidative processes within 
the cell, have been shown to be involved in regulatory mechanisms that are 
controlled in part, by insulin.  In some cases this is not an energetically favorable 
phenomenon, as witnessed by the mitochondrial dysfunction that often accompanies 
obesity as well as insulin resistance. 
  This idea was demonstrated in a study that examined respiratory function in 
mitochondria from human skeletal muscle after exposure to insulin and/or fatty acid 
[44].  Vastus lateralis muscle biopsies were obtained from lean, obese and obese type 
2 diabetic (T2D) individuals.  Utilizing a cell culture model, HSkMCs were isolated 
from biopsy samples, grown in culture and differentiated to myotubes for 
experimentation.  On days 5 or 6 of differentiation, myotubes were treated with 1 µM 
insulin, 0.6 mM palmitate or co-incubation of both for 4 hours. In isolated myotube 
mitochondria, 3-hydroxyacyl-CoA (HAD) protein content was measured as an indicator 
of β-oxidation, whereas citrate synthase (CS) and hexokinase (HK) protein content 
were taken as a means to assess the ratio of oxidative to glycolytic metabolism.  Also, 
in an attempt to discern whether lower CS in obese T2Ds could be explained by lower 
mitochondrial content, NADH respiration was measured.  Major findings were that CS 
was significantly lower in myotubes derived from obese T2Ds in comparison to lean 
and severely obese controls [44].  Insulin stimulation significantly increased CS in 
myotubes derived from lean and severely obese individuals, however, this effect was 
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not observed in myotubes from obese T2Ds.  Moreover, this effect of insulin 
stimulation was eradicated with co-incubation of insulin and palmitate.  Regardless of 
the experimental condition, no significant differences in oxygen consumption were 
observed in any group, until normalized to CS.  These findings first highlight that CS is 
significantly lower in obese T2Ds under normo-physiological conditions that was not 
improved upon 4 hours of insulin treatment.  This suggests a metabolic impairment in 
oxidative enzymes for mitochondrial function that may be regulated by insulin and 
thus, defective in the insulin-resistant state [44].  This study also illustrates the 
dangers high fatty acid as myotubes from lean and severely obese individuals 
functioned to a level of obese T2Ds upon exposure to only 4 hours of high palmitate 
[44].   
In contrast, a similar, more recent study examined the influence of insulin 
resistance induced by high insulin and/or saturated fatty acids on mitochondrial 
function [45].  C2C12 cells were grown in culture and treated with 100 nM of insulin 
for 24 or 48 hours (on days 3 and 5 of differentiation). For experiments with fatty 
acid, C2C12 myotubes were treated with palmitate at various concentrations. Findings 
were that 48 hours of insulin treatment induced insulin resistance through impaired 
PI3K signaling as proteins associated with this pathway were significantly reduced 
[45].  Researchers also found that 48 hours of insulin significantly increased oxygen 
consumption, lowered mitochondrial membrane potential and lowered mitochondrial 
reactive oxygen species (ROS) production. However, there were no changes in ATP 
content.  In addition, PGC-1α mRNA and uncoupling proteins 2 and 3 (UCP2 and UCP3) 
mRNAs were significantly reduced upon 48 hours insulin stimulation, though no 
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significant changes in oxidative phosphorylation complex proteins (Complexes I-V) 
were observed.   Conversely, fatty acid treatment resulted in a significant decrease in 
oxygen consumption, decrease in mitochondrial membrane potential and increase in 
electron transport chain (ETC/OXPHOS) subunits and UCP proteins [45].  Collectively, 
these data suggest that insulin resistance as a result of either prolonged exposure to 
insulin or saturated fatty acids results in adaptations in mitochondrial function.  
However, the changes seem to occur by two separate mechanisms [45].  It can be 
inferred, then, that there may exist a conditioned response of insulin to upregulate 
factors that can maintain a “normal” of level of mitochondrial function that is lost 
over time with the development of obesity/severe obesity.  
  
Chapter III 
Research Design & Methods 
Experimental Purpose 
Experiments for this thesis consisted of two components.  In the first set of 
studies, we wanted to examine the proliferation and differentiation characteristics of 
HSkMCs derived from lean and severely obese individuals under normo-physiological 
conditions. The second set of studies consisted of examining responses to insulin with 
respect to mitochondrial biogenesis and other indices of oxidative function.   
Human Participants 
 Before any testing procedures began, approval by the East Carolina University 
Policy and Review Committee on Human Research was obtained.  Participants 
included lean and severely obese women, matched in age and ethnicity.  Table 1 
outlines these characteristics. 
Muscle biopsies & HSkMCs 
 Muscle biopsies were taken from the vastus lateralis of each participant using 
the percutaneous needle biopsy technique [46].  From these biopsy samples, primary 
muscle cells were isolated and grown in culture [46].  These human skeletal muscle 
cells (HSkMCs) were transferred and sub-cultured in 12-well or 6-well type I collagen-
coated plates at densities of 40,000 to 60,000 cells per well.  Once the cells were 
approximately 80-90% confluent, they were switched from growth medium (DMEM 
[5mM glucose], 10%FBS, 1% BSA, 1% Fetuin, 0.1% Dexamethasone, 0.1% rhEGF, 1% Pen-
Strep) to differentiation medium (DMEM [5mM glucose], 1% Horse Serum, 0.3% BSA, 
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0.5% Fetuin, 1% Pen-Strep).  Procedures for primary muscle cell culture have been 
previously outlined in detail [46].    
Determination of Cellular Properties from HSkMCs 
Myoblast Proliferation 
In a sub-sample of cells derived from lean and severely obese individuals 
matched for age and ethnicity, proliferation experiments were performed.  24 hours 
after plating sub-cultured cells, cells were lifted (.05% Trypsin/EDTA) and viability 
was assessed using an automated cell counter (Beckman Coultre Vi-Cell).  Total cell 
counts were also determined using this cell counter.  To validate these proliferation 
measures, cells were counted using the MTT [3-(4, 5dimethylthiazolyl-2)-2, 5-
diphenyltetrazolium bromide] Cell Proliferation assay (Life Technologies), which 
measures the metabolic activity of cells utilizing NAD(P)H-dependent reactions.  Thus, 
the MTT provides somewhat of a combination of the measures obtained from the 
automated cell counter (Beckman Coultre Vi-Cell), as the MTT indicates the number 
of viable cells based off of the absorbance.  Each of these MTT experiments were also 
repeated at 48, & 72-hour time points. 
Visualization of Myotube Differentiation & Protein Determination 
 On day 7 of differentiation, myotubes in 6-well plates were fixed with 
methanol, permeabilized (0.1% Triton-X100 in PBS), stained with DAPI [(2-(4-
amidinophenyl)-1H -indole-6-carboxamidine,] (Sigma Aldrich) and performed 
immunofluorescence for total myosin heavy chain, MHC (MF20; DS Hybridoma Bank, 
University of Iowa).  Using the Pierce bicinchoninc acid assay (BCA), protein 
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concentrations of the samples were determined at days 2, 5 and 7 of differentiation.  
Using ImageJ64, the fusion index and myotube area were obtained. The fusion index 
was calculated as the ratio of nuclei in myotubes containing ≥ 3 nuclei to total nuclei 
per image.  Myotube area was calculated as the amount of myotubes per area of the 
image [43].  15 images were analyzed for 2 individuals per group for a total of 30 
images analyzed per lean and severely obese groups.  Western Blot analyses for 
specific protein content were also conducted at these time points (methodologies 
described in detail below).  
High-Insulin Treatment in Skeletal Muscle Myotubes 
For insulin-stimulation studies, on days 6 or 7 of differentiation, mature 
myotubes were treated with 100 nM insulin in a starvation medium (DMEM [5mM 
glucose], 1% BSA, 1% Pen-Strep) for 1, 3, 8, 16 or 24 hours. Basal conditions 
(starvation media only) at each time point were also included.  Myotubes in 6-well 
plates were washed with ice-cold PBS and treated with 250 μL of a lysis buffer (50mM 
HEPES, 50mM sodium pyrophosphate, 100mM sodium fluoride, 10mM EDTA, 10mM 
sodium orthovanadate).  Inhibitors (0.5% protease inhibitor cocktail [, 1% triton, and 
1% phosphatase cocktail 2 and 3) were added in order to protect protein from 
degradation (by proteases) and the removal of phosphates (by phosphatases) on 
proteins of interest.  After suspension in lysis buffer solution with inhibitors, cells 
were fully lysed by sonication and centrifuged at 12000 rpm for 15 minutes at 4°C. 
The pellets were discarded and cell lysates were analyzed using the Pierce BCA 
protein assay was performed for determination of protein concentrations in each 
samples. 
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Measures of Insulin and Metabolites from Culture Media 
 Measurements of insulin and related-metabolites was conducted across 1, 3, 8, 
16 & 24 hour time points. Directly after insulin-stimulation, 1.0 mL of sample was 
collected from a single well on a 6-well plate for the basal conditions at each time 
point for each subject.  For the insulin-stimulated conditions, 1.0 mL of sample was 
collected from two wells on the 6-well plate (1.0 mL per well for a total of 2.0 mL of 
sample per time point for each subject).  Each sample corresponded to the same 
subject and condition for a total of 2.0 mL per sample.  These samples were stored 
immediately at -80°C in Eppendorf tubes.  At the time of analysis, a 500 μL aliquot 
was inserted into a chemistry analyzer (Unicel DxC 600i; Beckman Coulter) and 
determinations of insulin, glucose and lactate from the culture media were obtained.  
Western Blot Analyses 
From the subsample of myotubes used to determine physical cell properties, 
18μg from each of the cell lysates were assayed for markers of differentiation (MyoD 
(M-318); Santa Cruz Biotech) and total myosin content (MHC (MF20); Hybridoma 
Bank).  For the samples that were treated with 100nM insulin at time points between 
1 and 24 hours, 18μg from each of these cell lysates were assayed for contents of the 
following markers of insulin signaling (p-AKT(Ser473) (9271), total AKT (9272); Cell 
Signaling) mitochondrial biogenesis (PGC-1α (ab106814); Abcam), electron transport 
chain (Total OXPHOS cocktail (ab110413); Abcam) and the slow isoform of myosin 
heavy chain (MYHC (BA-D5); DS Hybridoma Bank).  These experiments were performed 
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using SDS-PAGE and transfer to immobilon-fluorescent polyvinylidene difluoride 
membranes.  Each sample was normalized to a control sample on each gel (β-actin; . 
Determination of Intracellular ATP 
Immediately following 24 hours of insulin treatment, myotubes in the 6-well 
plates not being used for other assays were washed twice with ice-cold PBS.  PBS was 
then completely removed and the plates were put on ice.  For each well, 200 μL of 
0.5 N HClO4 was added, scraped for cellular content and transferred to chilled 
centrifuge tubes.  This step was repeated to ensure proper recovery of the cellular 
contents.  Samples collected were then sonicated for 10 seconds at 100% power, 
centrifuged at 12000 rpm for 10 minutes at 4°C.  250 μL of the supernatant was then 
transferred to new tubes and neutralized with 140 μL of ice cold 1.0 N KOH.  These 
samples were centrifuged at 12000 rpm for 10 minutes at 4°C, then 300 μL of this 
supernatant was collected and stored at -80°C until analysis of nucleotides was 
performed using Ultra-Performance Liquid Chromatography (UPLC) [91].  These 
included ATP, ADP and AMP.  From the previous pellet-containing tubes, residual 
liquid was completely removed using a pipette and the pellet was re-suspended in 300 
μL of 0.2 N NaOH. Protein concentrations of these samples were determined using the 
Pierce BCA protein assay. 
Citrate Synthase Activity 
 Citrate Synthase (CS) activity was determined using the Citrate Synthase Assay 
Kit (Sigma Aldrich).  Immediately following insulin stimulation, myotubes in 12-well 
plates not being used for other assays were washed twice with ice cold PBS and 
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treated with 125 μL of the CelLytic™ M Cell Lysis Reagent for 15 minutes on a shaker 
at 4°C.  Cells were then scraped for cellular content and transferred to chilled 
centrifuge tubes that were stored at  80°C until later analyzed for protein 
concentrations via Pierce BCA.  Once protein concentrations were determined, 
samples of at least 8 μg were combined with a reaction buffer also containing Acetyl 
Co-A and DTNB [5,5'-Dithiobis-(2-nitrobenzoic acid)], in 96-well plates. Oxaloacetic 
acid was added last after obtaining background activity from the sample and the rate 
of the reaction was also measured on a microplate reader (Synergy H1 Hybrid Reader, 
Biotek) at 412 nm. 
Statistical Analyses 
Repeated-measures ANOVA, two-way ANOVA, and both paired and unpaired T-
tests were used to analyze these data.  Values are represented as the mean ± SEM 
unless stated otherwise. 
  
  
Chapter IV 
Results 
Determination of Cellular Properties: 
Similar Proliferation and Differentiation Patterns in HSkMCs from Lean and Severely 
Obese Individuals 
Measures of proliferation were carried out in two ways.  Using the MTT assay, 
we found no differences in myoblast cell count between and lean and severely obese 
groups.  With respect to time, we found that myoblast cell count in both groups was 
significantly increased at 48 (p < 0.001) and 72 hours (p < 0.001) compared to the 24-
hour time point (Figure 1A).  Using the Beckman Coultre Vi-Cell to obtain total 
myoblast cell number, we found no differences in total myoblast cell number between 
lean and severely obese groups. With respect to time, we found that total cell 
number in both groups was significantly increased at 48 (p < 0.001) and 72 hours (p < 
0.001) (Figure 1B).  Percent cell viability in myoblasts was also measured across 24, 
48 and 72-hour time points in both lean and severely obese groups.  We observed 
significant increases in cell viability in both lean and severely obese groups at 48 (p = 
0.01) and 72 hours (p = 0.02).  However, cell viability did not differ between lean and 
severely obese groups (Figure 1C).   
Measures of differentiation were carried out in two ways.  At day seven of 
differentiation, myotubes were stained with antibodies against DAPI and total MYHC 
for visualization of nuclei and myotubes (representative image shown in Figure 2A).  
ImageJ software analysis revealed that at day 7 of differentiation, both the fusion 
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index was and myotube area were not different between lean and severely obese 
groups (Figure 2B, 2C).   
At the protein level, we found that at days 2, 5 and 7 of differentiation, MyoD, 
nor total MYHC, were different between lean and severely obese groups (Figures 3A, 
3B).  We also observed no changes in MyoD content in either group over time.  
However, total MYHC protein content was significantly increased in both groups at day 
5 of differentiation (p = 0.01) in comparison to day 2 (Figure 3B).  Total MYHC protein 
content at day 7 also tended to be higher in both groups compared to day 2, however, 
this did not reach statistical significance (p = 0.06). 
Insulin Incubation Study: 
Comparable Changes in Insulin, Glucose & Lactate from Culture Media  
 As anticipated, we were not able to detect substantial amounts of insulin from 
culture media obtained in CTRL(-) (non-insulin) conditions across time points (i.e., .  
Thus, our results/data analyses for insulin obtained from culture media consider only 
the insulin-stimulated states between lean and severely obese groups.  We found that 
insulin obtained from culture media under insulin-stimulated conditions was not 
different between lean and severely obese groups.  We also found that insulin 
significantly decreased in both groups at 3 hours (p < 0.001), 8 hours (p < 0.001), 16 
hours (p < 0.001) and 24 hours (p < 0.001) compared to the 1-hour time point (Figure 
4A). 
There were no differences in glucose obtained from culture media with insulin 
treatment between the lean and severely obese groups.  Glucose levels obtained from 
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culture media were significantly decreased over time in both lean and severely obese 
groups (p < 0.001) (Figure 4B, 4C).  Also, glucose levels were significantly decreased 
at 8 hours (p = 0.05), 16 hours (p < 0.001) and 24 hours (p < 0.001) compared to the 1-
hour time point.   
We also found that insulin significantly increased lactate levels in culture 
media from both lean and severely obese groups (p < 0.001).  Lactate levels also 
increased significantly with time (p < 0.001) (Figure 4D, 4E).  Furthermore, lactate 
levels were significantly higher at 16 hours (p = 0.02) and 24 hours (p = 0.03) 
compared to the 1-hour time point in both lean and severely obese groups (p = 0.02).  
Still, lactate obtained from culture media was not different between lean and 
severely obese groups with insulin stimulation. 
Insulin Stimulation of AKT Phosphorylation  
Across time points, there were no differences in protein content in CTRL(-) 
conditions between lean and severely obese groups for AKT phosphorylation.  At the 
1, 8, 16 and 24-hour time points, we found that insulin significantly increased AKT 
phosphorylation (Ser473) in both lean and severely obese groups (p = 0.02, 0.03, 0.01 
and 0.02, respectively) (Figure 5).  At the 1-hour time point, however, AKT 
phosphorylation with insulin stimulation was 51% lower in the obese group compared 
to lean (p = 0.05). 
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Insulin Upregulates Myosin Heavy Chain Content (slow form) 
Across time points, there were no differences in protein content in CTRL(-) 
conditions between lean and severely obese groups for the protein content MYHC 
(slow isoform).  Surprisingly, at the 1, 8, 16 and 24-hour time points, insulin 
significantly increased MYHC (slow isoform) protein content in both lean and severely 
obese groups (p = 0.03, 0.01, 0.002 and 0.05, respectively) (Figure 6).   
PGC-1α & Mitochondrial Content (OXPHOS Proteins) are Unchanged with High-Insulin 
Treatment  
Across time points, there were no differences in protein content in CTRL(-) 
conditions between lean and severely obese groups for PGC-1α protein content.  We 
also found no changes in PGC-1α protein content with insulin treatment in either lean 
or obese groups (Figure 7).  Across time points, there were no differences in protein 
content in CTRL(-) conditions between lean and severely obese groups for Complex V 
(ATP Synthase).  At the 16-hour time point, insulin significantly decreased Complex V 
protein content (Figure 8).  Across time points, there were no differences in protein 
content in CTRL(-) conditions between lean and severely obese groups for Complex III 
protein content.  Additionally, we found no changes in Complex III protein content 
with insulin treatment in either the lean or obese groups (Figure 9).  Across time 
points, there were no differences in protein content in CTRL(-) conditions between 
lean and severely obese groups for Complex IV protein content.  At the 1-hour time 
point, there were trends for increased Complex IV protein content with insulin 
treatment in both lean and severely obese groups though this measure did not reach 
25 
 
statistical significance (p = 0.07) (Figure 10).  At the 3-hour time point, however, 
insulin significantly increased Complex IV protein content in both lean and severely 
obese groups (p = 0.02).  Furthermore, we found that at the 8-hour time point, 
Complex IV protein content was 39% higher in the obese group compared to lean (p = 
0.02).  Complexes I and II were probed in these experiments, but were not 
consistently detected in our samples. Therefore, they were excluded from these 
analyses.   
Downward Shifts in Nucleotides ATP, ADP & AMP with High-Insulin  
For these experiments, only the 24 hour time point was examined.  In 
myotubes derived from lean individuals, there was no effect of 24 hours of insulin on 
the levels of ATP, ADP or AMP (Figure 11A, 11B, 11C).  In myotubes derived from 
obese individuals, we found that ADP levels decreased 78% from CTRL(-) with 24 hours 
of insulin treatment (p = 0.04) (Figure 11B).  Also in the obese group, AMP levels 
decreased 83% from CTRL(-) with 24 hours of insulin treatment (p = 0.04) (Figure 
11C).  In CTRL(-) conditions, ADP levels were 38% higher in obese compared to lean (p 
= 0.04).  We also observed no differences in the ratios of ADP:ATP (Figure 11D) or 
AMP:ATP (Figure 11E) with insulin treatment within or between lean and severely 
obese groups. We were also unable to detect any IMP levels from these measures.   
High-Insulin may Stimulate Changes in Citrate Synthase Activity 
For these experiments, insulin stimulation was conducted in a sub-sample of 
individuals from the experiments mentioned above for 3 hours and repeated at a 24-
hour time point.  At the 3-hour time point, there were no effects of insulin on CS 
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activity in either lean or obese groups (Figure 12A).  There were also no differences 
between groups in CS activity in CTRL(-) conditions.  In myotubes obtained from obese 
individuals, CS activity was 21% higher with 24-hours insulin treatment (p = 0.05) 
(Figure 12B). 
  
  
Chapter V 
Discussion 
 In this study, skeletal muscle myotubes derived from lean and severely obese 
humans were challenged with 100nM insulin over the course of 24 hours and examined 
for mitochondrial biogenesis.  Before conducting these experiments, we classified the 
cellular properties of these human skeletal muscle cells (HSkMCs) and to our 
knowledge, we are the first to report these data as it relates to lean and severely 
obese individuals. 
In regards to myoblast proliferation, our data suggests that lean and severely 
obese individuals exhibit similar patterns of growth up through 72 hours, with the 
most growth occurring between the first 24-48 hours (Figures 1A, 1B).  This is 
consistent with data obtained from time-lapse image analyses in recent years [54].  At 
present, when utilizing this HSkMC model, we begin the differentiation process once 
myoblasts are 80-90% confluent, which typically occurs between 48 & 72 hours at 
densities ranging from 30,000 – 50,000 cells [46]. For this study, we chose a seeding 
density of ~40,000 cells per well in 6-well plates.  Our proliferation data suggest that 
at these densities, beginning the differentiation process at either 48 or 72-hour time 
points is methodologically valid. 
 In regards to myotube differentiation, which is of increasing importance due to 
evidence suggesting that myogenic potential of skeletal muscle is impaired with 
obesity [55-58], we find a story similar to that of proliferation.  In the present study, 
at day 7 of differentiation, immunofluorescent analyses revealed that myotubes from 
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lean and severely obese individuals exhibit similar morphology as indicated by total 
nuclei and total MYHC content (Figure 2A).  The fusion index has been used to 
investigate similar questions regarding the formation and/or alteration of skeletal 
muscle in vitro [59]. However, this index has not been extensively used to examine 
differences as it relates to obesity-related issues, as findings from one study indicate 
no differences between healthy/lean and severely obese groups [60].  Similarly, our 
protein data (Figures 3A, 3B) are aligned with our imaging data suggesting that 
myotubes from lean and severely obese individuals express similar levels of myogenic 
proteins over a differentiation period of 7 days.  In our HSkMC experiments, we 
terminate the differentiation process and begin experimentation between days 5 and 
7.  These data would suggest that doing so is appropriate as myotubes from lean and 
severely obese individuals demonstrate similar differentiation patterns/muscle 
protein levels at this time. 
There are other known markers that contribute to skeletal muscle proliferation 
and differentiation [61, 62, 63].  MyoD is suggested to be the most significant 
transcriptional regulator of muscle differentiation [64] with its largest role in 
fast/glycolytic fibers [65].  Downstream of MyoD is myogenin, which is considered a 
late marker of myogenesis.  Myf5 has been shown to greatly contribute to the 
development of skeletal muscle as well [66, 67].  In addition, Myf5 is thought to work 
in conjunction with MyoD and/or other myogenic factors to regulate muscle 
differentiation.  The roles of these proteins were substantiated, when a group of 
researchers found that in a triple knockout mouse model (lacking MyoD, MRF4 and 
Myogenin), Myf5 alone was inadequate to upregulate skeletal muscle differentiation 
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in vitro [68].  Our study could have provided even more robust data about muscle 
regeneration with obesity if Myf5, Myogenin and MRF4 were included.  We would 
anticipate that these proteins, similar to MyoD, would be similar between lean and 
severely obese individuals and may be reduced in type 2 diabetes (or the combination 
of severe obesity and type 2 diabetes).  We have already observed some dysregulation 
in the myogenic program in vitro as indicated by MyoD (and total MYHC) content in 
severely obese type 2 diabetic populations (data not shown). 
From the findings in the present study, we conclude that human skeletal 
muscle cells derived from lean and severely obese individuals demonstrate patterns of 
proliferation and differentiation over time that are nearly identical.  This study 
provides additional evidence to support the use of HSkMCs from these populations to 
address questions concerning skeletal muscle function, metabolism and/or disease. 
The work in this thesis also addressed the question of whether high-insulin 
treatment would upregulate proteins associated with mitochondrial biogenesis in 
vitro, across time.  As a means to be sure this experimental approach kept our system 
intact, we monitored the changes is insulin as well as glucose and lactate from the 
extracellular environment (culture/starvation media [DMEM (5mM glucose), 1% BSA, 
.01% Pen-Strep]).  We found that insulin gradually decreased over time in both lean 
and severely obese groups (Figure 4A).  Though not statistically significant, we noted 
a trend for insulin levels to be lower in the obese groups at the 1 and 3-hour time 
points.  However, it is difficult to speculate why this occurred, which is one of the 
limitations of our study.  The maximal detection limit for this method is 319 µIU/mL 
and as a result, we diluted our samples when measuring insulin (40x dilution).  The 
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data shown (Figure 4A) accounts for these dilutions, and it is possible these diluted 
samples may be associated with these discrepancies between groups at the early time 
points.  Still, it is of note that insulin levels are decrease over time (as anticipated) 
and are maintained at supra-physiological levels at the “chronic,” 24-hour time point 
in both groups (~4,000 µIU/mL or ~28 nM). 
For glucose obtained from culture media, we observed noticeable decreases 
over time in both lean and severely obese groups (Figures 4B, 4C).  Though these 
changes are not completely reflective of the intracellular environment, these data 
imply that skeletal muscle myotubes are exceptional at preserving glucose with 
insulin treatment over time.  Lactate obtained from culture media increased with 
both time and insulin both groups (Figures 4D, 4E), suggesting that the little glucose 
that was taken up by the myotubes was utilized (and utilization was highest when 
glucose levels were lowest). 
With a lack of current research using similar methodological techniques, it is 
difficult to compare these data with existing literature. However, these findings 
demonstrate that the extracellular adaptations to high-insulin in both lean and 
severely obese groups are comparable.   
Following high-insulin exposure in these myotubes derived from lean and 
severely obese individuals, we found that insulin stimulated phosphorylation of AKT in 
both lean and severely obese groups (Figure 5).  Furthermore, we found that at the 
earliest (1-hour) time point, AKT phosphorylation (Ser473) in myotubes from the obese 
group was half (51%) that of AKT phosphorylation in the lean group.  This data provide 
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further evidence to the extensive reviews on the relationship between obesity and 
insulin resistance [69-72].  Why these group differences are not sustained at later 
time points in our study is uncertain.  However, there is evidence that this prolonged 
high-insulin exposure reduces AKT phosphorylation at this serine residue and also 
reduces glucose metabolism in muscle cells [73].  Moreover, the 24-hour time 
duration of 100nM insulin has been utilized as a means to induce insulin resistance in 
vitro [74].  In our study, 100nM insulin reduced a 3 fold increase in AKT 
phosphorylation at the first hour to only a ~50% increase at 24 hours (in myotubes 
from lean individuals).  From this perspective, these data are reflective of the idea 
that these myotubes can be pushed to adopt an insulin resistant phenotype with 
supra-physiological insulin levels in as little as 24 hours. 
The slow isoform of MYHC increased with 100nM insulin in both lean and 
severely obese groups nearly all time points, including 24 hours (Figure 6).  It has 
been established that MYHC can be transcriptionally regulated [75] and/or post-
translationally modified [76] as a result of insulin action.  However, our data slightly 
contrasts what has been reported previously in vivo, as 3-hours insulin exposure 
increased fast MYHC (type IIx) mRNAs while MYHC type I mRNAs were unchanged [42].  
These discrepancies may exist due to the fact that the present study was conducted 
in vitro, with a much higher stimulus of insulin. Still, keeping in mind that slow fibers 
contain more insulin receptors [29], and have been positively associated with insulin 
sensitivity [77, 78], it is practical that high levels of insulin would upregulate the slow 
isoform of MYHC in this study.  Additionally, research has long established that 
mammalian target of rapamycin (mTOR), is a crucial regulator of protein synthesis in 
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skeletal muscle [79, 80, 81].  Though we did not measure mTOR and/or mTOR 
phosphorylation, the increases in AKT phosphorylation observed in this study would 
support that the stimulus provided by insulin would be associated with increases in 
protein synthesis [81, 82, 83] as indicated by increases in the slow form of MYHC. 
With respect to intracellular nucleotides, previous literature has shown that 
ATP synthesis rates are increased with acute high-insulin treatment in skeletal muscle 
(and that this effect is reduced in an excessive lipid environment) [84, 85].  In 
contrast, chronic, insulin-stimulated ATP synthesis in skeletal muscle has not been 
thoroughly investigated.  In this study, ATP trended to decrease in myotubes from 
both lean and severely obese individuals.  We also found no differences in CTRL(-) 
ATP levels, which is consistent with previous research [86].  In addition, the ratios of 
ADP:ATP and AMP:ATP remained constant with insulin treatment in both groups.  The 
significant decreases in ADP and AMP with insulin treatment that were also observed 
(in obese groups only), as well as the group differences in CTRL(-) ADP levels are 
puzzling and could be (re)investigated in larger samples sizes or utilizing other 
methodologies (i.e., isolated mitochondria) [86, 87].  Still, these data along with the 
non-detectable levels of IMP (in both groups) suggest a shift in the entire nucleotide 
pool as well as a balance between ATP synthesis and degradation.  Taken together 
with our previous (MYHC) data, we conclude that 24 hours high-insulin exposure may 
be associated with decreased nucleotide levels as a result of increased protein 
synthesis, and that this process occurs in a similar fashion in myotubes from both lean 
and severely obese individuals. 
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As mentioned, a recent study examining the effects of insulin on ATP synthesis 
in skeletal muscle with obesity found no differences between lean and obese groups 
[86].  Interestingly, these similarities were observed in myotubes from lean and obese 
groups with comparable mitochondrial mass.  These data provide additional evidence 
to the idea that altered/reduced mitochondrial-specific functions, rather than 
mitochondrial content alone, are an integral part of the metabolic problems observed 
with obesity and/or obesity-related disorders (i.e., insulin resistance).  This may also 
explain why we observed no changes in PGC-1α, or ETC/OXPHOS proteins (Complexes 
III & V).  We do not deny, however, the possibility that gene expression and/or post-
translational modifications of mitochondrial proteins are occurring as these 
phenomena have been established [16, 17].  Our findings do, however, illustrate the 
significance of Complex IV, as it was higher and significantly increased with high-
insulin treatment at the 1-hour and 3-hour time points, respectively.  This effect was 
witnessed in both lean and severely obese groups, though we did find that this effect 
was statistically higher in the obese group at the 8-hour time point.  Why this 
difference exists is also unclear.  Still, the acute responses in Complex IV content 
with high-insulin treatment is logical, as OXPHOS genes have been shown to be 
insulin-sensitive in skeletal muscle (and adipose tissue as well) [88, 89, 90].   
It is difficult to interpret our measures of CS activity with high-insulin 
treatment with such small sample sizes in comparison to other experiments (n = 2 per 
group vs. n = 5 to 6).  If these experiments are repeated, it is likely that insulin-
stimulated increases in CS activity at 3 hours would be significant in both lean and 
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severely obese groups, as that has been shown to occur in myotubes/isolated 
mitochondria [44]. 
In closing, we conclude from this study that myotubes from lean and severely 
obese individuals behave similarly with respect to their proliferative behavior, and 
are morphologically alike at the time of differentiation.  These HSkMCs are valuable 
experimental tools that aided in filling the gap(s) in current research about the 
hormonal regulation of mitochondrial biogenesis, specifically by insulin.   Given the 
data from the present study, it is suggested that increases in muscle protein, rather 
than mitochondrial protein, are favored under circumstances in which an overload of 
anabolic stimuli (supra-physiological insulin levels) are present.  We deem that 
continued use of the HSkMC culture would be beneficial for expanding our knowledge 
about the relationship between insulin and more functional outcomes relevant to the 
mitochondria (i.e., lipid oxidation, ATP synthesis rates, oxygen consumption).  Such 
findings would also assist in advancing even further our understanding of how 
metabolic adaptations in skeletal muscle are disrupted in obese and/or insulin-
resistant populations.  
  
References 
1. Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2013). Prevalence of 
obesity among adults: United states, 2011-2012. NCHS Data Brief, (131) (131), 
1-8. 
2. Janssen, I., Heymsfield, S. B., Wang, Z. M., & Ross, R. (2000). Skeletal muscle 
mass and distribution in 468 men and women aged 18-88 yr. Journal of Applied 
Physiology (Bethesda, Md.: 1985), 89(1), 81-88.  
3. Hensrud, D. D., & Klein, S. (2006). Extreme obesity: A new medical crisis in the 
United States. Mayo Clinic Proceedings, 81(10 Suppl), S5-10.  
4. Eckardt, K., Taube, A., & Eckel, J. (2011). Obesity-associated insulin resistance 
in skeletal muscle: Role of lipid accumulation and physical inactivity. Reviews 
in Endocrine & Metabolic Disorders, 12(3), 163-172.  
5. DeFronzo, R. A., & Tripathy, D. (2009). Skeletal muscle insulin resistance is the 
primary defect in type 2 diabetes. Diabetes Care, 32 Suppl 2, S157-63.  
6. Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994). Mechanisms 
of fatty acid-induced inhibition of glucose uptake. The Journal of Clinical 
Investigation, 93(6), 2438-2446.  
7. Laakso, M., Edelman, S. V., Olefsky, J. M., Brechtel, G., Wallace, P., & Baron, 
A. D. (1990). Kinetics of in vivo muscle insulin-mediated glucose uptake in 
human obesity. Diabetes, 39(8), 965-974.  
8. Peiris, A. N., Struve, M. F., Mueller, R. A., Lee, M. B., & Kissebah, A. H. (1988). 
Glucose metabolism in obesity: Influence of body fat distribution. The Journal 
of Clinical Endocrinology & Metabolism, 67(4), 760-767. 
36 
 
9. Santos, R. X., Correia, S. C., Alves, M. G., Oliveira, P. F., Cardoso, S., 
Carvalho, C., et al. (2014). Insulin therapy modulates mitochondrial dynamics 
and biogenesis, autophagy and tau protein phosphorylation in the brain of type 
1 diabetic rats. Biochimica Et Biophysica Acta, 1842(7), 1154-1166.  
10. Parra, V., Verdejo, H. E., Iglewski, M., Del Campo, A., Troncoso, R., Jones, D., 
et al. (2014). Insulin stimulates mitochondrial fusion and function in 
cardiomyocytes via the akt-mTOR-NFkappaB-opa-1 signaling pathway. Diabetes, 
63(1), 75-88.  
11. Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & 
Kelley, D. E. (2005). Deficiency of subsarcolemmal mitochondria in obesity and 
type 2 diabetes. Diabetes, 54(1), 8-14. 
12. Ritov, V. B., Menshikova, E. V., Azuma, K., Wood, R., Toledo, F. G., 
Goodpaster, B. H., et al. (2010). Deficiency of electron transport chain in 
human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. 
American Journal of Physiology. Endocrinology and Metabolism, 298(1), E49-
58.  
13. Jornayvaz, F. R., & Shulman, G. I. (2010). Regulation of mitochondrial 
biogenesis. Essays in Biochemistry, 47, 69-84.  
14. Liu, S., Okada, T., Assmann, A., Soto, J., Liew, C. W., Bugger, H., et al. 
(2009). Insulin signaling regulates mitochondrial function in pancreatic beta-
cells. PloS One, 4(11), e7983. 
37 
 
15. Liu, H. Y., Yehuda-Shnaidman, E., Hong, T., Han, J., Pi, J., Liu, Z., et al. 
(2009). Prolonged exposure to insulin suppresses mitochondrial production in 
primary hepatocytes. The Journal of Biological Chemistry, 284(21), 14087-
14095.  
16. Zhao, X., Bak, S., Pedersen, A. J., Jensen, O. N., & Hojlund, K. (2014). Insulin 
increases phosphorylation of mitochondrial proteins in human skeletal muscle 
in vivo. Journal of Proteome Research, 13(5), 2359-2369.  
17. Stump, C. S., Short, K. R., Bigelow, M. L., Schimke, J. M., & Nair, K. S. (2003). 
Effect of insulin on human skeletal muscle mitochondrial ATP production, 
protein synthesis, and mRNA transcripts. Proceedings of the National Academy 
of Sciences of the United States of America, 100(13), 7996-8001. 
18. Pessin, J. E., & Saltiel, A. R. (2000). Signaling pathways in insulin action: 
Molecular targets of insulin resistance. The Journal of Clinical Investigation, 
106(2), 165-169. 
19. Whelan, S. A., Dias, W. B., Thiruneelakantapillai, L., Lane, M. D., & Hart, G. 
W. (2010). Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-
mediated insulin signaling by O-linked beta-N-acetylglucosamine in 3T3-L1 
adipocytes. The Journal of Biological Chemistry, 285(8), 5204-5211.  
20. Hemmings, B. A., & Restuccia, D. F. (2012). PI3K-PKB/Akt pathway. Cold Spring 
Harbor Perspectives in Biology, 4(9), a011189.  
21. Hemmings, B. A., & Restuccia, D. F. (2015). The PI3K-PKB/Akt pathway. Cold 
Spring Harbor Perspectives in Biology, 7(4), 10.1101 
38 
 
22. Metz, H. E., & Houghton, A. M. (2011). Insulin receptor substrate regulation of 
phosphoinositide 3-kinase. Clinical Cancer Research: An Official Journal of the 
American Association for Cancer Research, 17(2), 206-211. 
23. Kim, H. Y., Choi, H. J., Lim, J. S., Park, E. J., Jung, H. J., Lee, Y. J., et al. 
(2011). Emerging role of akt substrate protein AS160 in the regulation of AQP2 
translocation. American Journal of Physiology. Renal Physiology, 301(1), F151-
61.  
24. Goodyear, L. J., Giorgino, F., Sherman, L. A., Carey, J., Smith, R. J., & Dohm, 
G. L. (1995). Insulin receptor phosphorylation, insulin receptor substrate-1 
phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in 
intact skeletal muscle strips from obese subjects. The Journal of Clinical 
Investigation, 95(5), 2195-2204. 
25. Brozinick, J. T., Jr, Roberts, B. R., & Dohm, G. L. (2003). Defective signaling 
through akt-2 and -3 but not akt-1 in insulin-resistant human skeletal muscle: 
Potential role in insulin resistance. Diabetes, 52(4), 935-941. 
26. Sano, H., Kane, S., Sano, E., Miinea, C. P., Asara, J. M., Lane, W. S., et al. 
(2003). Insulin-stimulated phosphorylation of a rab GTPase-activating protein 
regulates GLUT4 translocation. The Journal of Biological Chemistry, 278(17), 
14599-14602. 
27. Kramer, H. F., Witczak, C. A., Taylor, E. B., Fujii, N., Hirshman, M. F., & 
Goodyear, L. J. (2006). AS160 regulates insulin- and contraction-stimulated 
glucose uptake in mouse skeletal muscle. The Journal of Biological Chemistry, 
281(42), 31478-31485. 
39 
 
28. Henriksen, E. J., Bourey, R. E., Rodnick, K. J., Koranyi, L., Permutt, M. A., & 
Holloszy, J. O. (1990). Glucose transporter protein content and glucose 
transport capacity in rat skeletal muscles. The American Journal of Physiology, 
259(4 Pt 1), E593-8. 
29. Albers, P. H., Pedersen, A. J., Birk, J. B., Kristensen, D. E., Vind, B. F., Baba, 
O., et al. (2015). Human muscle fiber type-specific insulin signaling: Impact of 
obesity and type 2 diabetes. Diabetes, 64(2), 485-497. 
30. Hickey, M. S., Carey, J. O., Azevedo, J. L., Houmard, J. A., Pories, W. J., 
Israel, R. G., et al. (1995). Skeletal muscle fiber composition is related to 
adiposity and in vitro glucose transport rate in humans. The American Journal 
of Physiology, 268(3 Pt 1), E453-7. 
31. Tanner et al. 2002. American Journal of Physiology. Endocrinology and Metab 
282: E1191–E1196. 
32. Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, 
O., et al. (2008). Mitochondrial overload and incomplete fatty acid oxidation 
contribute to skeletal muscle insulin resistance. Cell Metabolism, 7(1), 45-56. 
33. Jheng, H. F., Tsai, P. J., Guo, S. M., Kuo, L. H., Chang, C. S., Su, I. J., et al. 
(2012). Mitochondrial fission contributes to mitochondrial dysfunction and 
insulin resistance in skeletal muscle. Molecular and Cellular Biology, 32(2), 
309-319. 
34. Boyle, K. E., Zheng, D., Anderson, E. J., Neufer, P. D., & Houmard, J. A. 
(2012). Mitochondrial lipid oxidation is impaired in cultured myotubes from 
obese humans. International Journal of Obesity (2005), 36(8), 1025-1031.  
40 
 
35. Vijgen, G. H. E. J., Bouvy, N. D., Hoeks, J., Wijers, S., Schrauwen, P., & van 
Marken Lichtenbelt, W. D. (2013). Impaired skeletal muscle mitochondrial 
function in morbidly obese patients is normalized one year after bariatric 
surgery. Surgery for Obesity and Related Diseases, 9(6), 936-941.  
36. Bikman, B. T., Zheng, D., Pories, W. J., Chapman, W., Pender, J. R., Bowden, 
R. C., et al. (2008). Mechanism for improved insulin sensitivity after gastric 
bypass surgery. The Journal of Clinical Endocrinology and Metabolism, 93(12), 
4656-4663. 
37. Reed, M. A., Pories, W. J., Chapman, W., Pender, J., Bowden, R., Barakat, H., 
et al. (2011). Roux-en-Y gastric bypass corrects hyperinsulinemia implications 
for the remission of type 2 diabetes. The Journal of Clinical Endocrinology and 
Metabolism, 96(8), 2525-2531. 
38. Albers, P. H., Bojsen-Moller, K. N., Dirksen, C., Serup, A. K., Kristensen, D. E., 
Frystyk, J., et al. (2015). Enhanced insulin signaling in human skeletal muscle 
and adipose tissue following gastric bypass surgery. American Journal of 
Physiology. Regulatory, Integrative and Comparative Physiology, 
ajpregu.00228.2014. 
39. Saltiel, A. R., & Kahn, C. R. (2001). Insulin signaling and the regulation of 
glucose and lipid metabolism. Nature, 414(6865), 799-806. 
40. Gil, J., Miralpeix, M., Carreras, J., & Bartrons, R. (1988). Insulin-like effects of 
vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the 
liver of diabetic rats. The Journal of Biological Chemistry, 263(4), 1868-1871. 
41 
 
41. Noguchi, T., Inoue, H., & Tanaka, T. (1985). Transcriptional and post-
transcriptional regulation of L-type pyruvate kinase in diabetic rat liver by 
insulin and dietary fructose. The Journal of Biological Chemistry, 260(26), 
14393-14397. 
42. Houmard, J. A., O'Neill, D. S., Zheng, D., Hickey, M. S., & Dohm, G. L. (1999). 
Impact of hyperinsulinemia on myosin heavy chain gene regulation. Journal of 
Applied Physiology (Bethesda, Md.: 1985), 86(6), 1828-1832. 
43. Bollinger, L. M., Powell, J. J., Houmard, J. A., Witczak, C. A., & Brault, J. J. 
(2015). Skeletal muscle myotubes in severe obesity exhibit altered ubiquitin-
proteasome and autophagic/lysosomal proteolytic flux. Obesity (Silver Spring, 
Md.), 23(6), 1185-1193. 
44. Ortenblad, N., et al. (2005). Reduced insulin-mediated citrate synthase activity 
in cultured skeletal muscle cells from patients with type 2 diabetes: Evidence 
for an intrinsic oxidative enzyme defect. Biochimica Et Biophysica Acta, 
1741(1-2), 206-214. 
45. Yang, C., Aye, C. C., Li, X., Diaz Ramos, A., Zorzano, A., & Mora, S. (2012). 
Mitochondrial dysfunction in insulin resistance: Differential contributions of 
chronic insulin and saturated fatty acid exposure in muscle cells. Bioscience 
Reports, 32(5), 465-478. 
46. Berggren, J. R., Tanner, C. J., & Houmard, J. A. (2007). Primary cell cultures 
in the study of human muscle metabolism. Exercise and Sport Sciences 
Reviews, 35(2), 56-61. 
42 
 
47. Zou, K., Hinkley, J.M., Billings, S., Park, S. Zheng, D., Jones, T., Hornsby, P., 
Lenhard, J., Pories, W., Dohm, G. L., & Houmard, J. (2015). Glucose 
metabolism is impaired in cultured myotubes from severely obese humans. The 
FASEB Journal, 29(1), 944. 
48. Gaster, M., Petersen, I., Højlund, K., Poulsen P., & Beck-Nielsen H. (2002). The 
diabetic phenotype is conserved in myotubes established from diabetic 
subjects: evidence for primary defects in glucose transport and glycogen 
synthase activity. Diabetes, 51(4), 921-927. 
49. Kim, J. Y., Hickner, R. C., Cortright, R. L., Dohm G. L. & Houmard, J. A. 
(2000). Lipid oxidation is reduced in obese human skeletal muscle. American 
Journal of Physiology. Endocrinology and Metabolism, 279(5), E1039–E1044. 
50. Souza, D. M., Al-Sajee D., & Hawke, T. J. (2013). Diabetic myopathy: impact of 
diabetes mellitus on skeletal muscle progenitor cells. Frontiers in Physiology, 
4, 00379       
51. Madi H.A., Riches, K., Warburton, P., O’Regan D.J., Turner N. A., & Porter K. 
E. (2009). Inherent differences in morphology, proliferation, and migration in 
saphenous vein smooth muscle cells cultured from nondiabetic and type 2 
diabetic patients. American Journal of Cell Physiology, 297, C1307–C1317. 
52. Pomies et al. (2015). Reduced myotube diameter, atrophic signaling and 
elevated oxidative stress in cultured satellite cells from COPD patients. Journal 
of Cellular and Molecular Medicine, 19, 175-186. 
43 
 
53. Covington, J.D., et al. (2015).  Effect of serial cell passaging in the retention of 
fiber type and mitochondrial content in primary human myotubes. Obesity 
Biology and Integrated Physiology, 23, 2414–2420. 
54. Siegel, A. L., Kuhlmann, P. K., & Cornelison, D. D. W.  (2011). Muscle satellite 
cell proliferation and association: new insights from myofiber time-lapse 
imaging. Skeletal Muscle, 1(7). 
55. Nguyen, M., Cheng, M., & Koh, T.J. (2011).  Impaired muscle regeneration in 
ob/ob and db/db mice. TheScientificWorldJOURNAL, 11, 1525-1535. 
doi:10.1100/tsw.2011.137 
56. Hu, Z., Wang, H., Lee, I.H., Modi, S., Wang, X., Du, J. & Mitch, W. E. (2010). 
PTEN inhibition improves muscle regeneration in mice fed a high-fat diet. 
Diabetes, 59(6), 1312–1320. 
57. Fu, X., Zhu, M., Zhang, S., Foretz, M. Viollet, B., & Du, M. (2016). Obesity 
impairs skeletal muscle regeneration through inhibition of AMPK. Diabetes, 
65(1), 188-200.  
58. Akhmedov, D., & Berdeaux, R. (2013). The effects of obesity on skeletal muscle 
regeneration. Frontiers in Physiology, 4, 371.  
59. Tamilarasan, K. P., et al. (2012). Skeletal muscle damage and impaired 
regeneration due to LPL-mediated lipotoxicity. Cell Death and Disease, 3, 
e354.  
60. Scheele, C., Nielsen, S., Kelly, M., Broholm, C., & Nielsen, A. R. (2012). 
Satellite cells derived from obese humans with type 2 diabetes and 
44 
 
differentiated into myocytes in vitro exhibit abnormal response to IL-6. PLoS 
ONE, 7(6), e39657. 
61. Braun, T., & Gautel, M. (2011). Transcriptional mechanisms regulating skeletal 
muscle differentiation, growth and homeostasis. Nature Reviews Molecular Cell 
Biology, 12, 349-361. 
62. Francetic, T., & Li, Q. (2011). Skeletal myogenesis and Myf5 activation. 
Transcription, 2(3), 109–114. 
63. Angione, A. R., Jiang, C., Pan, D., Wang, Y., & Kuang, S. (2011). PPARδ 
regulates satellite cell proliferation and skeletal muscle regeneration. Skeletal 
Muscle, 1(33).  
64. Tapscott, S. J. (2005). The circuitry of a master switch: Myod and the 
regulation of skeletal muscle gene transcription. Development. 132(12), 2685-
2695. 
65. Hughes, S. M., Taylor, J. M., Tapscott, S. J., Gurley, C. M., Carter, W. J., & 
Peterson, C. A. (1993). Selective accumulation of MyoD and myogenin mRNAs in 
fast and slow adult skeletal muscle is controlled by innervation and hormones. 
118(4), 1137-1147. 
66. Rudnicki, M. A., Schnegelsberg, P. N., Stead, R. H., Braun, T., Arnold, H. H., & 
Jaenisch, R. (1993). MyoD or Myf-5 is required for the formation of skeletal 
muscle. Cell, 75(7), 1351-1359. 
67. Ustanina, S., Carvajal, J., Rigby, P., & Braun, T. (2007). The myogenic factor 
myf5 supports efficient skeletal muscle regeneration by enabling transient 
myoblast amplification. STEM CELLS, 25, 2006-2016. 
45 
 
68. Valdez, M. R., Richardson, J. A., Klein, W. H., & Olsen, E. N. (2000).  Failure of 
Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.  
Developmental Biology, 15; 219(2), 287-298. 
69. Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. Journal of 
Clinical Investigation, 106(4), 473–481.  
70. Qatanani, M., & Lazar, M. A. (2007). Mechanisms of obesity-associated insulin 
resistance: many choices on the menu. GENES & DEVELOPMENT, 21, 1443-1445. 
71. McArdle, M. A., Finucane, O. M., Connaughton, R. M, McMorrow, A. M., & 
Roche, H. M. (2013). Mechanisms of obesity-induced inflammation and insulin 
resistance: insights into the emerging role of nutritional strategies. Frontiers in 
Endocrinology, 4(52), 1-23. 
72. Tewari, N., Award, S., Macdonald, I. A., & Lobo, D. N. (2015). Obesity-related 
insulin resistance: implications for the surgical patient. International Journal 
of Obesity (2015) 39, 1575–1588. 
73. Bertacca, A., et al. (2005).  Continually high insulin levels impair Akt 
phosphorylation and glucose transport in human myoblasts. Metabolism, 
54(12), 1687-1693. 
74. Fröjdö, S., et al. (2011).  Phosphoinositide 3-kinase as a novel functional target 
for the regulation of the insulin signaling pathway by SIRT1. Molecular and 
Cellular Endocrinology, 335, 166–176. 
75. Pontecorvi, A., Tata, J. R., Phyillaier, M., & Robbins, J. (1988). Selective 
degradation of mRNA: the role of short-lived proteins in differential 
destabilization of insulin-induced creatine phosphokinase and myosin heavy 
46 
 
chain mRNAs during rat skeletal muscle L6 cell differentiation. The EMBO 
Journal, 7(5), 1489–1495. 
76. Goel, H. L., & Dey, C.S. (2002). Insulin-mediated tyrosine phosphorylation of 
myosin heavy chain and concomitant enhanced association of c-terminal src 
kinase during skeletal muscle differentiation. Cell Biology International, 26(6), 
557-561. 
77. Hickey, M. S., Weidner, M. D., Gavigan, K. E., Zheng, D., Tyndall, G. L., & 
Houmard, J. A. (1995). The insulin action-fiber type relationship in humans is 
muscle group specific. American Journal of Physiology - Endocrinology and 
Metabolism, 269(1), E150-E154. 
78. Stuart, C. A., et al. (2013). Slow-twitch fiber proportion in skeletal muscle 
correlates with insulin responsiveness. The Journal of Clinical Endocrinology 
and Metabolism, 98(5), 2027–2036. 
79. Dennis, P. B., Fumagalli, S., & Thomas, G. (1999). Target of rapamycin (TOR): 
Balancing the opposing forces of protein synthesis and degradation. Current 
Opinion in Genetics & Development, 9(1), 49-54. 
80. Drummond, M. J., Fry, C. S., Glynn, E. L., Dreyer, H. C., Dhanani, S., 
Timmerman, K. L., Volpi, E. and Rasmussen, B. B. (2009). Rapamycin 
administration in humans blocks the contraction-induced increase in skeletal 
muscle protein synthesis. The Journal of Physiology, 587, 1535–1546. 
81. Bodine, S. C. et al. (2001). Akt/mTOR pathway is a crucial regulator of skeletal 
muscle hypertrophy and can prevent muscle atrophy in vivo. Nature Cell 
Biology, 3, 1014-1019.  
47 
 
82. Kitamura, T., et al (1998). Requirement for activation of the serine-threonine 
kinase AKT (protein kinase b) in insulin stimulation of protein synthesis but not 
of glucose Transport. Molecular and Cellular Biology, 18(7), 3708–3717.  
83. Mammucari, C., Schiaffino, S., & Sandri, M. (2008). Downstream of Akt: FoxO3 
and mTOR in the regulation of autophagy in skeletal muscle. Autophagy, 4(4), 
524–526. 
84. Brehm, A., et al (2006). Increased lipid availability impairs insulin-stimulated 
ATP synthesis in human skeletal muscle. Diabetes, 55(1), 136-140. 
85. Yerby, B., et al. (2008). Insulin-stimulated mitochondrial adenosine 
triphosphate synthesis is blunted in skeletal muscles of high-fat–fed rats. 
Metabolism, 57(11), 1584-1590. 
86. Minet, A. D., & Gaster, M. (2010). ATP synthesis is impaired in isolated 
mitochondria from myotubes established from type 2 diabetic subjects. 
Biochemical and Biophysical Research Communication, 1(5), 70-74. 
87. Gaster, M. (2011). Mitochondrial mass is inversely correlated to complete lipid 
oxidation in human myotubes. Biochemical and Biophysical Research 
Communications, 4(28), 1023-1028. 
88. Huang, X., Eriksson, K. F., Vaag, A., Lehtovirta, M., Hansson, M., Laurila, E., 
Kanninen, T., Olesen, B. T., Kurucz, I., Koranyi, L., & Groop, L. (1999). Insulin-
regulated mitochondrial gene expression is associated with glucose flux in 
human skeletal muscle. Diabetes, 48(8), 1508-1514. 
89. Katic, M., Kennedy A. R., Leykin, I., Norris, A., McGettrick, A., Gesta, S., 
Russell, S. J., Bluher, M., Maratos-Flier, E., & Kahn, C. R. (2007). Mitochondrial 
48 
 
gene expression and increased oxidative metabolism: role in increased lifespan 
of fat-specific insulin receptor knock-out mice. Aging Cell, 6(6), 827-839. 
90. Skov, V., Dorte, G., Steen, K., Jensen, T., Kruse, T. A., Tan, Q., Brusgaard, K., 
Beck-Nielson, H., & Højlund, K. (2007). Reduced expression of nuclear-encoded 
genes involved in mitochondrial oxidative metabolism in skeletal muscle of 
insulin-resistant women with polycystic ovary syndrome. Diabetes, 56(9), 2349-
2355. 
91. Brault et al. (2013). Selective inhibition of ATPase activity during contraction 
alters the activation of p38 MAP kinase isoforms in skeletal muscle Journal of 
Cellular Biochemistry, 114(6). 
 
  
49 
 
Figures 
 
 
Figure 1.  Proliferation in myoblasts derived from lean and severely obese individuals. 
Cells isolated from skeletal muscle biopsies were grown in culture sub-cultured on collagen-
coated plates at densities of ~35,000-40,000 cells for these proliferation experiments.  24 
hours post-plating, (1A) the (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide 
(MTT) assay was used to obtain a cell count.  (1B) Cells not being used for this experiment 
were assessed using an automated cell counter (Beckman Coultre).  (1C) Cell viability was 
also assessed using this cell counter. Each of these experiments were repeated at 48 & 72-
hour time points. Across time points, myoblast cell count, total myoblast number and 
myoblast cell viability were not different between lean and severely obese groups.  Data are 
expressed as the mean ± SEM. #Statistical difference from 24 hrs at p ≤ 0.05.   
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Figure 2.  Differentiation in myotubes from lean and severely obese individuals. 
(2A) Myotubes were stained with antibodies against nuclei (DAPI) and total myosin heavy 
chain (MYHC) at day 7 of differentiation at 20x magnification.  Quantifications of (2B) fusion 
index and (2C) myotube area. Fusion index and myotube area were not different between 
lean and severely obese groups. Data are expressed as the mean ± SEM.  
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Figure 3.  Markers of differentiation in myotubes from lean and severely obese 
individuals. 
(3A) MyoD and (3B) total myosin heavy chain (MYHC) protein content in myotubes at days 2, 5 
and 7 of differentiation. Across time points, the protein content was not different between 
lean and severely obese groups for MyoD or total MYHC. Data are expressed as the mean ± 
SEM.  #Statistical difference from day 2 at p ≤ 0.05.   
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Figure 4.  Insulin and metabolites from culture media after 100nM insulin exposure. 
One hour after insulin exposure, (4A) insulin (only insulin-stimulated states are shown), (4B, 
4C) glucose and (4D, 4E) lactate were collected from the starvation media in which myotubes 
were incubating in.  This process was repeated at 3, 8, 16 and 24-hour time points and 
assayed using a chemistry analyzer (Unicel DxC 600i; Beckman Coulter).  Across time points, 
the fold change from CTRL(-) was not different between lean and severely obese groups for 
insulin, glucose or lactate.  Data are expressed as the mean ± SEM.  $Effect of insulin at p ≤ 
0.05. #Statistical difference from 1 hr at p ≤ 0.05.    
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Figure 5.  Phosphorylation of AKT(Ser473) after 100nM insulin exposure in myotubes from 
lean and severely obese individuals.  Western Blot quantifications for p-AKT at 1, 3, 8, 16 
and 24-hr time points in lean and severely obese groups.  Data are expressed as the fold 
change from CTRL ± SEM.  $Effect of insulin at p ≤ 0.05. *Statistical difference from lean at 
p ≤ 0.05.   
 
 
Figure 6.  MYHC (slow isoform) protein content after 100nM insulin exposure in myotubes 
from lean and severely obese individuals.  Western Blot quantifications for MYHC (slow) at 
1, 3, 8, 16 and 24-hr time points in lean and severely obese groups.  Across time points, the 
fold change from CTRL(-) was not different between lean and severely obese groups for MYHC 
(slow isoform). Data are expressed as the fold change from CTRL ± SEM.  $Effect of insulin at 
p ≤ 0.05. 
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Figure 7.  PGC-1α protein content after 100nM insulin exposure in myotubes from lean 
and severely obese individuals.  Western Blot quantifications for PGC-1α at 1, 3, 8, 16 and 
24-hr time points in lean and severely obese groups.  Across time points, the fold change from 
CTRL(-) was not different between lean and severely obese groups for PGC-1α. 
 
 
Figure 8.  Complex V (ATP Synthase) protein content after 100nM insulin exposure in 
myotubes from lean and severely obese individuals.  Western Blot quantifications for 
Complex V at 1, 3, 8, 16 and 24-hr time points in lean and severely obese groups.  Across time 
points, the fold change from CTRL(-) was not different between lean and severely obese 
groups for Complex V.  Data are expressed as the fold change from CTRL ± SEM. $Effect of 
insulin at p ≤ 0.05.   
55 
 
 
Figure 9.  Complex III protein content after 100nM insulin exposure in myotubes from lean 
and severely obese individuals.  Western Blot quantifications for Complex III at 1, 3, 8, 16 
and 24-hr time points in lean and severely obese groups.  Across time points, the fold change 
from CTRL(-) was not different between lean and severely obese groups for Complex III.  Data 
are expressed as the fold change from CTRL ± SEM. 
 
Figure 10.  Complex IV protein content after 100nM insulin exposure in myotubes from 
lean and severely obese individuals.  Western Blot quantifications for Complex IV at 1, 3, 8, 
16 and 24-hr time points in lean and severely obese groups.  Data are expressed as the fold 
change from CTRL ± SEM. $Effect of insulin at p ≤ 0.05. *Statistical difference from lean at p 
≤ 0.05. 
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Figure 11.  Intracellular nucleotides ATP, ADP & AMP after 100nM insulin exposure in 
myotubes from lean and severely obese individuals.  Levels of (A) ATP, (B) ADP, and (C) 
AMP after 24 hours of 100nM insulin exposure in lean and severely obese groups.  Ratios of (D) 
ADP:ATP and (E) AMP:ATP after 100nM insulin exposure in lean and severely obese groups.  
Data are expressed as the mean ± SEM. $Effect of insulin at p ≤ 0.05. *Statistical difference 
from lean at p ≤ 0.05.  
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Figure 12.  Citrate Synthase activity after 100nM insulin exposure in myotubes from lean 
and severely obese individuals.  CS activity after 100 nM insulin exposure at (A) 3 and (B) 24-
hour time points in lean and severely obese groups.  Data are expressed as the mean ± SEM. 
$Effect of insulin at p ≤ 0.05.  
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Table 1. Participant Characteristics. Participant characteristics are outlined for the 
participants of these studies. Data are expressed as the mean ± standard deviation. 
*Statistical difference from lean at p ≤ 0.05.  
 
Participant Characteristics Lean (n = 6) Obese (n = 6) 
Age (yrs.) 
 
32.0 ± 7.2 35.6 ± 7.1 
Ethnicity (AA/Caucasian) 2/4 2/4 
Height (in.) 
 
66.3 ± 2.5 65.1 ± 1.7 
Weight (lbs.) 
 
155.1 ± 19.7 268.5 ± 57.3* 
BMI (kg/m2) 
 
25.0 ± 3.9 44.5 ± 8.1* 
Fasting Glucose (mg/dL) 
 
90.8  ± 6.7  92.2  ± 7.6 
Insulin (µIU/mL) 
 
9.6 ± 5.1 14.9 ± 6.2 
HOMA-IR 
 
2.1 ± 1.2 3.3 ± 1.3 
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Supplemental Figure 1. Representative western blots.  Western blots are shown for various 
proteins examined in both starved (-) and insulin-treated (+) conditions at 1, 3, 8, 16 or 24 
hour time points (from days 6 to 7 of differentiation). Proteins were normalized to β-actin 
(and p-AKT(Ser473) normalized to total AKT).   
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Supplemental Figure 2. Quantifications of Normalization Proteins.  Histograms are shown 
for (S2-A) total AKT and (S2-B) β-actin in both starved (-) and insulin-treated (+) conditions at 
1, 3, 8, 16 or 24 hour time points. Across time points, the fold change from CTRL(-) was not 
different between lean and severely obese groups for AKT β-actin. There were also no effects 
of time for total AKT or β-actin.  
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